A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study

Authors

• Amy E DeZern, Johns Hopkins University
• Matthew Walter, Washington University School of Medicine in St. Louis
• et al.

Journal

Blood Advances

Publication Date

4-28-2026

Volume

10

Issue

8

First Page

2743

Last Page

2753

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2025018770

Rights and Permissions

DeZern AE, Gillis N, Otterstatter M, Abel G, Padron E, Deeg HJ, Al Baghdadi T, Liu J, Xie Z, Zhang L, Moscinski L, Kroft S, Harrington A, Foran J, Komrokji R, Starczynowski D, Gore S, Saber W, Bejar R, Lindsley RC, Sherman S, Lee C, DiFronzo N, Walter M, Sekeres MA. A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study. Blood Adv. 2026 Apr 28;10(8):2743-2753. doi: 10.1182/bloodadvances.2025018770. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution.

Recommended Citation

DeZern, Amy E; Walter, Matthew; and et al., "A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study." Blood Advances. 10, 8. 2743 - 2753. (2026).
https://digitalcommons.wustl.edu/oa_4/7468

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.